CA1003836A - 1-(3-(5,6,7,8-tetrahydronaphth-1-yloxy)-propyl)-piperazine derivatives - Google Patents

1-(3-(5,6,7,8-tetrahydronaphth-1-yloxy)-propyl)-piperazine derivatives

Info

Publication number
CA1003836A
CA1003836A CA176,440A CA176440A CA1003836A CA 1003836 A CA1003836 A CA 1003836A CA 176440 A CA176440 A CA 176440A CA 1003836 A CA1003836 A CA 1003836A
Authority
CA
Canada
Prior art keywords
tetrahydronaphth
yloxy
propyl
piperazine derivatives
piperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA176,440A
Other languages
English (en)
Other versions
CA176440S (en
Inventor
Gisbert Sponer
Kurt Stach
Karl Dietmann
Ernst-Christian Witte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of CA1003836A publication Critical patent/CA1003836A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA176,440A 1972-07-20 1973-07-13 1-(3-(5,6,7,8-tetrahydronaphth-1-yloxy)-propyl)-piperazine derivatives Expired CA1003836A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2235597A DE2235597A1 (de) 1972-07-20 1972-07-20 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CA1003836A true CA1003836A (en) 1977-01-18

Family

ID=5851155

Family Applications (1)

Application Number Title Priority Date Filing Date
CA176,440A Expired CA1003836A (en) 1972-07-20 1973-07-13 1-(3-(5,6,7,8-tetrahydronaphth-1-yloxy)-propyl)-piperazine derivatives

Country Status (14)

Country Link
US (1) US3947446A (et)
JP (1) JPS5331158B2 (et)
AR (1) AR196775A1 (et)
AT (1) AT330188B (et)
CA (1) CA1003836A (et)
CH (2) CH583721A5 (et)
DD (1) DD106842A5 (et)
DE (1) DE2235597A1 (et)
ES (1) ES416929A1 (et)
FR (1) FR2193598B1 (et)
GB (1) GB1376588A (et)
HU (1) HU165887B (et)
NL (1) NL149168B (et)
ZA (1) ZA734811B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.
DE2658762A1 (de) * 1976-12-24 1978-06-29 Hoechst Ag Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB1583372A (en) * 1977-04-04 1981-01-28 Degussa 1-(3-(3,4,5-trimethoxyphenoxy)-2-hydroxypropyl)-4-aryl piperazine derivatives
US4101723A (en) * 1977-04-05 1978-07-18 E. R. Squibb & Sons, Inc. Substituted piperazinopropanols
US4259327A (en) * 1979-04-02 1981-03-31 Merck & Co., Inc. Substituted aminoalkoxypyridines, compositions and use thereof
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
DE3918542A1 (de) * 1989-06-07 1990-12-13 Boehringer Mannheim Gmbh Hydroxylierte 1-phenyl-4-(3-(napthth-1-yl-oxy)-2-hydroxy -propyl)-piperazine, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IT1255178B (it) * 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
CA2332275A1 (en) * 1998-05-14 1999-11-18 Zoltan Tamas Nagy Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
EP1425261A2 (de) * 2001-08-31 2004-06-09 Bayer Chemicals AG Verfahren zur herstellung von 4-amino-1-naphtholethern

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317034A (en) * 1970-11-06 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy- or -phenylthiopropyl-piperazine derivatives

Also Published As

Publication number Publication date
US3947446A (en) 1976-03-30
FR2193598A1 (et) 1974-02-22
DD106842A5 (et) 1974-07-05
JPS4943990A (et) 1974-04-25
FR2193598B1 (et) 1977-07-15
HU165887B (et) 1974-12-28
AR196775A1 (es) 1974-02-19
ES416929A1 (es) 1976-03-01
CH583722A5 (et) 1977-01-14
AT330188B (de) 1976-06-25
ZA734811B (en) 1974-07-31
NL149168B (nl) 1976-04-15
DE2235597A1 (de) 1974-01-31
NL7310041A (et) 1974-01-22
GB1376588A (en) 1974-12-04
CH583721A5 (et) 1977-01-14
JPS5331158B2 (et) 1978-08-31
ATA636673A (de) 1975-09-15

Similar Documents

Publication Publication Date Title
CA1015361A (en) Substituted 1,2,4-triazole derivatives
CA989410A (en) 1-(3,4-methylenedioxy-phenyl)-4,4-dimethyl-1-pentene derivatives
CA999589A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
AU471402B2 (en) Morpholine derivatives
CA1012534A (en) 2,6-diaminonebularine derivatives
CA999588A (en) 2,2,6,6-tetramethylpiperidinyl-4-acetic acid derivatives
CA1003836A (en) 1-(3-(5,6,7,8-tetrahydronaphth-1-yloxy)-propyl)-piperazine derivatives
CA1026760A (en) 3,4-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
CA1019733A (en) Pyrimidino-dibenzo-azepine, dibenzo-oxazepine, -thiazepine and -diazepine derivatives
CA1025448A (en) 1,3-benzodioxole derivatives
CA1033752A (en) 2,3-disubstituted 7-oxabicyclo-(2.2.1)-5-heptene derivatives
CA1029726A (en) 1,8-naphthyridine-3-carboxamidetetrazolyl derivatives
AU465122B2 (en) 1- [3-(5,6,7,8-tetrahydronapth-1-yloxy)-propyl] - piperazine derivatives
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
CA961045A (en) 1-(1,3,-4-thiadiazol-2-yl)-imidazolidinone-(2) derivatives
AU474523B2 (en) Substituted 9,10-dihydroanthracenes
CA1023358A (en) 1-phosphoryl-5-amino-1,2,4-triazoles
AU472337B2 (en) 11, 12-secoprostaglandins
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
AU464730B2 (en) 1, 2, 3-thiadiazole derivatives
AU487239B2 (en) 2, 3-methanoprostaglandin derivatives
AU477537B2 (en) 3, 4-DIHYDRO-2H-NAPHTHALIN-lone-5-OXYPROPYLPIPERAZINE DERIVATIVES
AU480736B2 (en) 1, 2-diphenyl-ethane derivatives
CA914679A (en) 5-nitrofuryl-1,2,4-oxadiazine derivatives
CA892585A (en) Piperazine derivatives